Clinical Trials List
Protocol NumberALLG AML M22
Active
2023-02-01 - 2025-12-31
Phase II
Recruiting1
-
Trial Applicant
T-TOP Clinical Research Co., Ltd.
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/02/01
Investigators and Locations
Co-Principal Investigator
- - - Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- Wen-Chien Chou Division of Hematology & Oncology
- CHENG-HONG TSAI Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
20 participants
-
Global
70 participants